These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34585826)

  • 1. Cysteine-rich intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling.
    He HY; Hu L
    Kaohsiung J Med Sci; 2022 Jan; 38(1):49-58. PubMed ID: 34585826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma.
    Wang J; Zhou Y; Zhang D; Zhao W; Lu Y; Liu C; Lin W; Zhang Y; Chen K; Wang H; Zhao L
    EMBO J; 2022 Aug; 41(15):e110218. PubMed ID: 35775648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/
    Liu Y; Li W; Luo J; Wu Y; Xu Y; Chen T; Zhang W; Fu F
    Dis Markers; 2021; 2021():3566749. PubMed ID: 34413913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer.
    He G; Zou L; Zhou L; Gao P; Qian X; Cui J
    Cell Physiol Biochem; 2017; 44(3):897-906. PubMed ID: 29179181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma.
    Li HG; Zhao LH; Zhang ZH; Liu JZ; Ren K; Li SY; Su ZJ
    Cell Physiol Biochem; 2017; 43(5):2037-2046. PubMed ID: 29059670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression.
    Cho SB; Park YL; Park SJ; Park SY; Lee WS; Park CH; Choi SK; Heo YH; Koh YS; Cho CK; Chung IJ; Kim KK; Kim S; Joo YE
    Oncol Res; 2011; 19(3-4):115-23. PubMed ID: 21473287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRIP1 promotes cell migration, invasion and epithelial-mesenchymal transition of cervical cancer by activating the Wnt/β‑catenin signaling pathway.
    Zhang LZ; Huang LY; Huang AL; Liu JX; Yang F
    Life Sci; 2018 Aug; 207():420-427. PubMed ID: 29959029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-30a suppresses tumor progression by blocking Ras/Raf/MEK/ERK signaling pathway in hepatocellular carcinoma.
    Zhou K; Luo X; Wang Y; Cao D; Sun G
    Biomed Pharmacother; 2017 Sep; 93():1025-1032. PubMed ID: 28732393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.
    Baiz D; Dapas B; Farra R; Scaggiante B; Pozzato G; Zanconati F; Fiotti N; Consoloni L; Chiaretti S; Grassi G
    World J Gastroenterol; 2014 Jan; 20(3):795-803. PubMed ID: 24574752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway.
    Zhang Y; Mi L; Xuan Y; Gao C; Wang YH; Ming HX; Liu J
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4861-4868. PubMed ID: 30070317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.
    Ludyga N; Englert S; Pflieger K; Rauser S; Braselmann H; Walch A; Auer G; Höfler H; Aubele M
    Mol Cancer; 2013 Apr; 12():28. PubMed ID: 23570421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MKL1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling.
    Liu Z; Sun J; Li C; Xu L; Liu J
    BMC Cancer; 2021 Nov; 21(1):1184. PubMed ID: 34742274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.